Aurinia Pharmaceuticals Inc.

AUPH · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$83,433$48,875$94,172$231,900
Short-Term Investments$275,043$301,614$295,218$234,178
Receivables$36,544$24,089$13,483$15,414
Inventory$39,228$39,705$24,752$19,326
Other Curr. Assets$1,129$1,031$1,334$796
Total Curr. Assets$446,596$424,800$442,539$513,324
Property Plant & Equip (Net)$98,871$116,567$8,557$9,801
Goodwill$0$0$0$0
Intangibles$4,355$4,977$6,425$8,404
Long-Term Investments$0$201$0$0
Tax Assets$0$0$0$0
Other NC Assets$823$1,517$13,339$11,838
Total NC Assets$104,049$123,262$28,321$30,043
Other Assets$0$0$0$0
Total Assets$550,645$548,062$470,860$543,367
Liabilities
Payables$5,187$4,327$3,087$3,879
Short-Term Debt$0$0$0$0
Tax Payable$0$667$625$814
Deferred Revenue$11,002$4,813$3,148$190
Other Curr. Liab.$66,502$1,588$2,033$4,450
Total Curr. Liab.$97,763$77,188$46,107$40,646
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$11,107$10,911$12,166$15,950
Total NC Liab.$75,404$92,920$19,318$23,630
Other Liabilities$0$0$0$0
Cap. Leases$79,369$97,607$8,088$8,739
Total Liabilities$173,167$170,108$65,425$64,276
Equity
Pref Stock$0$0$0$0
Common Stock$1,187,696$1,200,218$1,185,309$1,177,051
Retained Earnings-$936,570-$942,322-$864,302-$756,122
AOCI-$647-$730-$1,061-$852
Other Equity$0$0$0$0
Total Equity$377,478$377,954$405,435$479,091
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$550,645$548,062$470,860$543,367
Net Debt-$83,433-$48,875-$94,172-$231,900
Aurinia Pharmaceuticals Inc. (AUPH) Financial Statements & Key Stats | AlphaPilot